Please click on the link below to have an overview from EMVO on the national Fee Models for 2021 – 2022. LoA EMVO
The latest communication from EMVO is now available regarding the successful deployment of Release 1.8 to PROD environment. LoA EMVO
Please click on the link below to find out the details of the latest Letter of Announcement from EMVO on Release 1.8 and a change to the “A99 – Possible counterfeit” code in the header field LoA EMVO
The latest Letter of Announcement from EMVO has been released, confirming the deployment date of Release 1.8 for PRD. Find out more here: EMVO LoA
OSMR announces that during week 45 (02 – 08 November) the alerts’ percentage out of the total transactions decreased to 0,05%. This is the figure agreed at European level in order for the medicines verification system to be considered fully functional and mature. Through the combined efforts of our partners – manufacturers through Marketing Authorization […]
Please find below the third issue of the OSMR Newsletter. NL – November 2020







